Застосування внутрішньовенних препаратів заліза в терапії залізодефіцитної анемії у пацієнтів з хронічною хворобою нирок

Authors :: Dmytro Ivanov
Ya.A. Dombrowski
Source :: KIDNEYS. :9-13
Publication Year :: 2021
Publisher :: Publishing House Zaslavsky, 2021.
Abstract: The article reviews the current recommendations on treating anemia in chronic kidney disease. It is emphasized on the priority appointment of iron preparations. The comparative characteristic of iron supplementation efficacy in chronic renal diseas is presented. Advantages of ferric carboxymaltose are discussed.

Subjects :: medicine.medical_specialty
Pathology
business.industry
IRON PREPARATIONS
Anemia
Intravenous iron
medicine.disease
Gastroenterology
FERRIC CARBOXYMALTOSE
Iron-deficiency anemia
Internal medicine
Iron supplementation
Medicine
In patient
business
Kidney disease

Tools